| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/02/2023 | 38.63% | Morgan Stanley | $12 → $11 | Maintains | Equal-Weight |
| 10/02/2023 | 63.83% | Needham | → $13 | Reiterates | Buy → Buy |
| 09/28/2023 | 76.43% | Barclays | $12 → $14 | Maintains | Overweight |
| 08/07/2023 | 51.23% | Morgan Stanley | $11 → $12 | Maintains | Equal-Weight |
| 08/03/2023 | 51.23% | Barclays | $11 → $12 | Maintains | Overweight |
| 08/03/2023 | 63.83% | Needham | → $13 | Reiterates | Buy → Buy |
| 05/18/2023 | 63.83% | Needham | → $13 | Reiterates | Buy → Buy |
| 05/05/2023 | 63.83% | Needham | → $13 | Reiterates | → Buy |
| 02/24/2023 | 26.02% | Credit Suisse | $9 → $10 | Maintains | Neutral |
| 02/24/2023 | 76.43% | Oppenheimer | $12 → $14 | Maintains | Outperform |
| 02/24/2023 | 38.63% | Barclays | $10 → $11 | Maintains | Overweight |
| 02/24/2023 | 63.83% | Needham | → $13 | Reiterates | → Buy |
| 12/19/2022 | 26.02% | Morgan Stanley | $9 → $10 | Maintains | Equal-Weight |
| 12/09/2022 | 63.83% | B. Riley Securities | → $13 | Initiates Coverage On | → Buy |
| 11/22/2022 | 13.42% | Credit Suisse | → $9 | Initiates Coverage On | → Neutral |
| 11/03/2022 | 13.42% | Morgan Stanley | $7 → $9 | Maintains | Equal-Weight |
| 08/04/2022 | -11.78% | Morgan Stanley | $6.5 → $7 | Maintains | Equal-Weight |
| 08/04/2022 | 19.72% | Credit Suisse | $12 → $9.5 | Maintains | Neutral |
| 07/26/2022 | 13.42% | Barclays | $13 → $9 | Maintains | Overweight |
| 07/14/2022 | -18.08% | Morgan Stanley | $9.5 → $6.5 | Maintains | Equal-Weight |
| 06/03/2022 | 89.04% | Oppenheimer | $20 → $15 | Maintains | Outperform |
| 05/11/2022 | 19.72% | Morgan Stanley | $8 → $9.5 | Maintains | Equal-Weight |
| 04/07/2022 | 152.05% | Oppenheimer | → $20 | Upgrades | Perform → Outperform |
| 02/07/2022 | 76.43% | Craig-Hallum | → $14 | Initiates Coverage On | → Buy |
| 11/16/2021 | 38.63% | Credit Suisse | → $11 | Initiates Coverage On | → Neutral |
| 07/06/2021 | 107.94% | Roth Capital | → $16.5 | Initiates Coverage On | → Buy |
| 07/06/2021 | — | Oppenheimer | Initiates Coverage On | → Perform | |
| 07/06/2021 | — | William Blair | Initiates Coverage On | → Outperform | |
| 07/06/2021 | 51.23% | B of A Securities | → $12 | Initiates Coverage On | → Buy |
| 07/06/2021 | 51.23% | Barclays | → $12 | Initiates Coverage On | → Overweight |
| 07/06/2021 | 63.83% | Canaccord Genuity | → $13 | Initiates Coverage On | → Buy |
| 07/06/2021 | 13.42% | Morgan Stanley | → $9 | Initiates Coverage On | → Equal-Weight |
| 07/06/2021 | 63.83% | Needham | → $13 | Initiates Coverage On | → Buy |
What is the target price for Zeta Global Holdings (ZETA)?
The latest price target for Zeta Global Holdings (NYSE: ZETA) was reported by Morgan Stanley on November 2, 2023. The analyst firm set a price target for $11.00 expecting ZETA to rise to within 12 months (a possible 38.63% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Zeta Global Holdings (ZETA)?
The latest analyst rating for Zeta Global Holdings (NYSE: ZETA) was provided by Morgan Stanley, and Zeta Global Holdings maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Zeta Global Holdings (ZETA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Zeta Global Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Zeta Global Holdings was filed on November 2, 2023 so you should expect the next rating to be made available sometime around November 2, 2024.
Is the Analyst Rating Zeta Global Holdings (ZETA) correct?
While ratings are subjective and will change, the latest Zeta Global Holdings (ZETA) rating was a maintained with a price target of $12.00 to $11.00. The current price Zeta Global Holdings (ZETA) is trading at is $7.94, which is out of the analyst's predicted range.